Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Mar 11, 22:14 PM 2010 
  NYSE  7353.24  25.57  Index Moved Up   NASDAQ  2368.46  9.51  Index Moved Up  		Search is sponsered by    
  



Processing
Collecting necessary data for SLXP...

Salix Pharmaceuticals Ltd. financials, fundamentals and performance

    
30.88
Intraday
 
One Month
(0.61)  Macroaxis: -1.94 Down   1.94%  
    
Salix Pharmaceuticals Ltd. is Bearish SLXP Salix Pharmaceuticals Ltd.
 Trade It Now
 
    
Macroaxis: United States NASDAQ
    
Market Cap 1.524B   Book Value 4.826   EBITDA -30.2M   Year Low 6.93   Year High 32.03   PEG Ratio 7.41   EPS -0.975   P/B Ratio 6.53   Short Ratio 3.30   Index Membership S&P 600 SmallCap   S&P    Sector Healthcare   Full Time Employees 280   Industry Drug Related Products   Open 31.27   High 31.405   Low 30.33   Last Close 31.49   Volume 2 M   Target Price 40.56   Current EPS -0.975   This Year EPS 0.10   Next Year EPS 1.46   This Year PE 314.90   Next Year PE 21.57  

30-Days Risk-Return Take

    
SalixRisk FreeMarket
    

Profile

    
Suggest       

Today

  
Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States.
 Macroaxis: United States GSPC   0.40 % Price Moved Up  
 
 Macroaxis: United States IXIC   0.40 % Price Moved Up  
 
 Macroaxis: United States NYA   0.35 % Price Moved Up  
 
 Macroaxis: thisRed SLXP   1.94 % Price Moved Down  
 
    
    
    

Performance   Embed Financials

    
    
Embed Financials
 Compare Salix To   
    
Perrigo  NBTY  Herbalife  Auxilium  USANA  Prestige  CHBT  China  Schiff  BJGP  Tiens  NUTR  Mannatech  Natural  Medical  Cyanotech 
 Risk & Return  Correlation
    

30-Days Moving Rating

    

Macroaxis Total Score 

    
4
Embed Financials
Current 30 Days Moving Rating
AuxiliumSalixTiensNaturalPrestige
    
SLXP financials    

Current Net Investing Interest   

0
    

Estimated Market Risk

 5.18
  actual daily
 
 28 %
of total potential
 
Market Risk score

Expected Return

 0.83
  actual daily
 
 34 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.16
  actual daily
 
 8 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of SLXP by adding it to a well-diversified portfolio
Diversify
    

 Last Intraday

    
 
(0.61)Macroaxis: -0.61 Up1.94%
 
31.49,31.49,30.88,30.88,31.405,30.33,30.88
 
31.4930.88
    

Partner Center